Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Effect on Carbohydrate Metabolism in Pre-Transplant Dialysis Patients
2024-514072-40-00Phase 4Completed
- Sponsor
- CHD Vendée
- Start
- Jun 2024
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in chronic kidney disease (CKD), sponsored by CHD Vendée. Primary endpoint: Change in glycemic profile from baseline to day 14. Started Jun 2024; status: completed.
02
Drugs
tacrolimus
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2024-514072-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514072-40-00.